Rotavirus Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

A Randomized Controlled Phase 3 Trial to Assess the Safety, Immunogenicity and Efficacy of a Trivalent Rotavirus P2-VP8 Subunit Vaccine in Prevention of Severe Rotavirus Gastroenteritis in Healthy Infants in Africa and India
Condition:   Rotavirus Infection of Children Interventions:   Biological: TV P2-VP8;   Biological: Rotarix Sponsors:   PATH;   Bill and Melinda Gates Foundation;   SK Bioscience Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 8, 2019 Category: Research Source Type: clinical trials